Market capitalization | $64.28b |
Enterprise Value | $82.09b |
P/E (TTM) P/E ratio | 37.43 |
EV/FCF (TTM) EV/FCF | 26.71 |
EV/Sales (TTM) EV/Sales | 4.07 |
P/S ratio (TTM) P/S ratio | 3.19 |
P/B ratio (TTM) P/B ratio | 2.48 |
Dividend yield | 1.71% |
Last dividend (FY24) | $3.80 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
18 Analysts have issued a Becton, Dickinson & forecast:
18 Analysts have issued a Becton, Dickinson & forecast:
Sep '24 |
+/-
%
|
||
Revenue | 20,178 20,178 |
4%
4%
|
|
Gross Profit | 10,853 10,853 |
33%
33%
|
|
EBITDA | 5,169 5,169 |
13%
13%
|
EBIT (Operating Income) EBIT | 2,883 2,883 |
19%
19%
|
Net Profit | 1,726 1,726 |
16%
16%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.
Head office | United States |
CEO | Thomas Polen |
Founded | 1897 |
Website | www.bd.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.